Αποτελέσματα Αναζήτησης
27 Μαρ 2024 · This economic evaluation study estimated the cost of production for insulins, SGLT2Is, and GLP1As, and, based on this, a sustainable cost-based price (CBP), and compared CBPs with the current lowest reported prices in 12 countries, collected in January 2023 from public databases.
22 Ιουν 2023 · Using the most recent evidentiary and analytical framework from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), we produced location-specific, age-specific, and sex-specific estimates of diabetes prevalence and burden from 1990 to 2021, the proportion of type 1 and type 2 diabetes in 2021, the proportion of the type 2 diab...
15 Ιαν 2018 · We estimated the diabetes-attributable costs using 2 different methodologies. Method 1 compared the difference in all-cause costs between patients with diabetes and matched controls, and the difference was considered to be the diabetes-associated costs.
19 Μαρ 2015 · Primary outcomes were the total costs, the direct costs, and the indirect costs of type 2 diabetes and the respective per capita estimates of these outcomes, as well as the impact of type 2 diabetes on employment chances, income, wages and lost work days.
This infographic shows worldwide healthcare expenditure due to diabetes in 2015 and 2040, by region
26 Απρ 2017 · Differences in methods and data used in past studies have limited comparisons of the cost of illness of diabetes across countries. We estimate the full global economic burden of diabetes in adults aged 20–79 years in 2015, using a unified framework across all countries.
1 Νοε 2023 · The total estimated cost of diagnosed diabetes in the U.S. in 2022 is $412.9 billion, including $306.6 billion in direct medical costs and $106.3 billion in indirect costs attributable to diabetes.
